00:36 , Sep 13, 2006 |  BC Extra  |  Financial News

Alvine raises $21 million

Autoimmune company Alvine (Palo Alto, Calif.) raised $21 million in a series A round led by Sofinnova Ventures. Prospect Venture Partners; InterWest Partners; Cargill Ventures; and Flagship Ventures also participated. Alvine's lead compound ALV001, an...
00:55 , Apr 21, 2006 |  BC Extra  |  Financial News

Sirtris closes $22M series C

Sirtris ( Cambridge , Mass.) raised $22 million in a series C round led by Bessemer Venture Partners. Other investors included Genzyme Ventures; QVT Fund LP; and Alexandria Real Estate Equities as well as existing...
08:00 , Mar 6, 2006 |  BioCentury  |  Emerging Company Profile

Corporate Profile

Sirtris Pharmaceuticals Inc. Cambridge, Mass. Technology: Sirtuin enzyme modulators Disease focus: Metabolic, Neurology Clinical status: Preclinical Founded: 2004 by Rich Aldrich, Richard Pops, Paul Schimmel, David Sinclair and Christoph Westphal University collaborators: NA Corporate partners:...
08:00 , Nov 17, 2003 |  BC Week In Review  |  Company News

Linguagen board of directors update

Linguagen Corp. , Cranbury, N.J.   Business: Other   Appointed: Robert Chefitz, general partner of NJTC Venture Fund; David Patchen, managing director of Cargill Ventures; and Lars Dybkjaer, investment director at Danisco Venture A/S  ...
07:00 , Oct 14, 2002 |  BioCentury  |  Finance

Ebb & Flow

After threatening to fall though its summer-long support level, the biotech group continued to show resilience last week. The BioCentury 100 index dipped below the key 900 threshold on Wednesday, when it closed at 883,...